Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum The recent endorsement by Jim Cramer of CVS Health Corporation (NYSE:CVS) has sent shockwaves through the investment community.
With a 21% year to date gain and impressive second quarter earnings report, it's clear why investors are drawn to this healthcare giant.
Cramer's enthusiasm for CVS is largely due to the company's acquisition of Aetna in 2018, which has proven to be a savvy move.